News
How Modern Solutions Are Transforming Dental Care
Dentistry has come a long way from the days of simple checkups and extractions. Today, modern solutions are reshaping the way people experience oral care, combining technology, patient-centered services, and financial accessibility. These changes aren’t just improving outcomes but...
News
How to Build Long-Term Financial Security Without Sacrificing Your Health Goals
Creating lasting financial security while maintaining your health can feel like a balancing act. On one hand, you want to build wealth, save for the future, and create a financial cushion against life’s uncertainties.
On the other hand, you recognize...
Business & Industry
FDA Targets Drugmakers with Letters in a Marketing Crackdown
After the FDA went on to state that it was taking on what it has understood to be misleading or deceptive direct-to-consumer pharmaceutical ads, the floodgates have gone on to open, and how?
In the first few days post the announcement,...
News
GSK to Invest $30bn in the U.S. R&D and Manufacturing
GSK plc looks forward to investing $30 billion all across the U.S. in terms of research and development as well as supply chain infrastructure in the next five years. This happens to include a novel $1.2 billion investment when...
News
$5bn Drug Manufacturing Plant in Virginia by Eli Lilly
Eli Lilly has gone on to announce its plans to build a $5bn drug manufacturing plant in Virginia on September 16. This announcement comes amidst the pressure from President Donald Trump to get more drug manufacturing to the U.S....
BioPharma
Korean Biopharma Market to Double Biopharma Exports By 2030
The South Korean government has gone on to hold the Bio Innovation Roundtable at Songdo Convensia in Incheon as per the theme K-Bio: Accelerating Innovation. The Ministry of Food and Drug Safety, the Ministry of Economy and Finance, the...
News
Matica Bio Gets a U.S. Biotech Commercial Manufacturing Deal
Matica Biotechnology, Inc., which happens to be a leading contract development and manufacturing organization (CDMO) that specializes in viral vector manufacturing in terms of cell and gene therapies, announced on September 15, a strategic commercial manufacturing deal along with...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read















